Microbiome Sequencing Services Market Research Report – Global Forecast till 2027

Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2027

ID: MRFR/HC/6063-HCR | February 2021 | Region: Global | 160 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global microbiome sequencing services market is expected to grow significantly over the forecast period. It is estimated that the global microbiome sequencing services market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017. A microbiome is the unique collection of trillions of microorganisms in and on an individual’s body. Microbiome sequencing is a diagnostic technique in which millions and billions of DNA strands can be parallelly sequenced.


The market of microbiome sequencing services is driven by factors such as rising demand for microbiome research, high investment in next-generation sequencing, and reduction in the cost of next-generation sequencing. For instance, according to the data published by the Wall Street Journal in 2016, venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015. Additionally, widening applications of microbiome sequencing and rise in the genome mapping programs are propelling the growth of the market.


On the other hand, the lack of skilled technicians, ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is thwarting the growth of microbiome sequencing services market to an extent.


Moreover, major companies in the market are involved in strategic collaborations to sustain their position in the market. For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator. This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.


Segmentation


The global microbiome sequencing services market has been segmented into technology, application, and end user. The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others. The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others. The market, by end user, has been segmented into research and academic institutes, pharmaceutical and biotechnology companies, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The microbiome sequencing services market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European microbiome sequencing services market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microbiome sequencing services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The microbiome sequencing services market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Microbiome Sequencing Services Market Share (%), by Region, 2017


Microbiome Sequencing Services Market


Source: World Health Organization (WHO), Institute of Medicine (IOM)


Geographically, the Americas is expected to dominate the global microbiome sequencing services market due to the increasing per capita healthcare expenditure, and the heavy adoption of new technology. Furthermore, rising expenses in research and development by healthcare bodies and the government is anticipated to drive the growth of the market in this region.


Europe showed a considerable amount of growth in the global microbiome sequencing services market. The market growth in this region is because of the presence of a well-established healthcare system and increase in chronic diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the microbiome sequencing services market.


Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. However, less capital investment and awareness regarding healthcare IT are restricting the market growth of this region.


On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. Moreover, the limited adoption of advanced healthcare facilities and limited access to treatment facilities is also expected to drive the growth of the market in the near future.


Global Microbiome Sequencing Services Market, by Technology



  • Sequencing by Litigation (SBL)

  • Sequencing by Synthesis (SBS)

  • Short Gun Sequencing

  • Targeted Gene Sequencing

  • RNA Sequencing

  • Others


Global Microbiome Sequencing Services Market, by Application



  • Gastrointestinal Diseases

  • Infectious Diseases

  • CNS Diseases

  • Oncology

  • Others


Global Microbiome Sequencing Services Market, by End User



  • Research and Academic Institutes

  • Pharmaceutical and Biotechnology Companies

  • Others


Global Microbiome Sequencing Services Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Global Microbiome Sequencing Services Market, by Key Players



  • Baseclear B.V.

  • Clinical Microbiomics A/S

  • EPIBIOME

  • Merieux Nutrisciences Corporations

  • Metabiomics Corp.

  • Microbiome Insights Inc.

  • Microbiome Therapeutics, LLC.

  • MR DNA

  • Rancho Biosciences

  • Second Genome

  • Ubiome, Inc.

  • Zymo Research Corp.


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities

  • Venture Capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 555.1 Million
  • 2027: Significant Value
  •   CAGR   19.22% (2018-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Technology, Application, and End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporations, Metabiomics Corp., Microbiome Insights Inc., Microbiome Therapeutics LLC., MR DNA, Rancho Biosciences, Second Genome, Ubiome Inc., Zymo Research Corp.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Rising demand for microbiome research
  • High investment in next-generation sequencing
  • Reduction in the cost of next-generation sequencing


  • Frequently Asked Questions (FAQ) :


    The global microbiome sequencing services market was valued at USD 555.1 million in 2017.

    The market is expected to exhibit a robust 19.22% CAGR over the forecast period from 2018 to 2023.

    The rising demand for microbiome research and next-generation sequencing is the major driver for the market.

    The Americas hold the dominant share in the market.

    Leading players in the microbiome sequencing services market include Baseclear, EPIBIOME, Metabiomics, MR DNA, Ubiome, and Zymo Research Corp., among others.

    Table of Contents:


    Chapter 1 Report Prologue

    Chapter 2 Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3 Research Methodology

    3.1 Overview

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4 Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    Chapter 5 Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Opportunity Analysis

    5.4 Pricing Analysis

    Chapter 6 Global Microbiome Sequencing Services Market, by Technology

    6.1 Overview

    6.2 Sequencing by Litigation (SBL)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Sequencing by Synthesis (SBS)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Short Gun Sequencing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5 Targeted Gene Sequencing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6 RNA Sequencing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7 Others

    Chapter 7 Global Microbiome Sequencing Services Market, by Application

    7.1 Overview

    7.2 Gastro-Intestinal Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Infectious Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 CNS Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 Oncology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.6 Others

    Chapter 8 Global Microbiome Sequencing Services Market, by End User

    8.1 Overview

    8.2 Research and Academic Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Pharmaceutical and Biotechnology Companies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Others

    Chapter 9 Global Microbiome Sequencing Services Market, by Region

    9.1 Overview

    9.2 Americas

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 Latin America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 South Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10 Competitive Landscape

    10.1 Overview

    10.2 Market Share Analysis

    Chapter 11 Company Profiles

    11.1 Baseclear B.V.

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Clinical Microbiomics A/S

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 EPIBIOME

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Merieux Nutrisciences Corporations

    11.4.1 Company Overview

    11.4.2 Product Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Metabiomics Corp.

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Microbiome Insights Inc.

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Microbiome Therapeutics, LLC.

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financial Overview

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 MR DNA

    11.8.1 Overview

    11.8.2 Product Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Rancho Biosciences

    11.9.1 Overview

    11.9.2 Product Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Second Genome

    11.10.1 Overview

    11.10.2 Product Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Ubiome, Inc.

    11.11.1 Overview

    11.11.2 Product Overview

    11.11.3 Financials

    11.11.4 Key Developments

    11.11.5 SWOT Analysis

    11.12 Zymo Research Corp.

    11.12.1 Overview

    11.12.2 Product Overview

    11.12.3 Financials

    11.12.4 Key Developments

    11.12.5 SWOT Analysis

    11.13 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s Viewpoint

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictions for the Microbiome Sequencing Services Industry

    Chapter 13 Appendix

    LIST OF TABLES

    Table 1 Global Microbiome Sequencing Services Market Synopsis, 2020-2027

    Table 2 Global Microbiome Sequencing Services Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 4 Global Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 5 Global Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 6 Global Microbiome Sequencing Services Market, by Region, 2020-2027(USD Million)

    Table 7 North America: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 8 North America: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 9 North America: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 10 North America: Microbiome Sequencing Services Market, by Country, 2020-2027 (USD Million)

    Table 11 Latin America: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 12 Latin America: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 13 Latin America: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 14 Europe: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 15 Europe: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 16 Europe: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 17 Europe: Microbiome Sequencing Services Market, by Region, 2020-2027 (USD Million)

    Table 18 Western Europe: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 19 Western Europe: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 20 Western Europe: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 21 Western Europe: Microbiome Sequencing Services Market, by Country, 2020-2027 (USD Million)

    Table 22 Eastern Europe: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 23 Eastern Europe: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 24 Eastern Europe: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 25 Asia-Pacific: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 26 Asia-Pacific: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 27 Asia-Pacific: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 28 Asia-Pacific: Microbiome Sequencing Services Market, by Country, 2020-2027 (USD Million)

    Table 29 Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

    Table 30 Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

    Table 31 Middle East & Africa: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

    Table 32 Middle East & Africa: Microbiome Sequencing Services Market, by Region, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Microbiome Sequencing Services Market

    Figure 3 Segmentation Market Dynamics for Global Microbiome Sequencing Services Market

    Figure 4 Global Microbiome Sequencing Services Market Share, by Technology, 2020 (%)

    Figure 5 Global Microbiome Sequencing Services Market Share, by Application, 2020 (%)

    Figure 6 Global Microbiome Sequencing Services Market Share, by End User, 2020 (%)

    Figure 7 Global Microbiome Sequencing Services Market Share, by Region, 2020 (%)

    Figure 8 North America: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

    Figure 9 Europe: Microbiome Sequencing Services Market Share, by Region, 2020 (%)

    Figure 10 Western Europe: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

    Figure 11 Asia-Pacific: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

    Figure 12 Middle East & Africa: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

    Figure 13 Global Microbiome Sequencing Services Market: Company Share Analysis, 2020 (%)

    Figure 14 Baseclear B.V.: Key Financials

    Figure 15 Baseclear B.V.: Segmental Revenue

    Figure 16 Baseclear B.V.: Geographical Revenue

    Figure 17 Clinical Microbiomics A/S: Key Financials

    Figure 18 Clinical Microbiomics A/S: Segmental Revenue

    Figure 19 Clinical Microbiomics A/S: Geographical Revenue

    Figure 20 Microbiome Insights Inc.: Key Financials

    Figure 21 Microbiome Insights Inc.: Segmental Revenue

    Figure 22 Microbiome Insights Inc.: Geographical Revenue

    Figure 23 Merieux Nutrisciences Corporation: Key Financials

    Figure 24 Merieux Nutrisciences Corporation: Segmental Revenue

    Figure 25 Merieux Nutrisciences Corporation: Geographical Revenue

    NOTE:

    This table of content is tentative and subject to change as the research progresses.

    -In Chapter 11, the top 10 companies will be profiled. Each company will be profiled on the basis of Market Overview, Financials, Product Portfolio, Business Strategies, & Recent Development parameters.

    -Please note: Financial details of the company cannot be provided if the information of the company is not available in the public domain and or reliable source



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.